Stock Financial Ratios, Dividends, Split History

HTBK / Heritage Commerce Corp. financial ratios include Market Cap, Enterprise Value, Book Value, Quick Ratio, Current Ratio, NCAV, EBITDA, Profit Margin, Operating Margin, Return on Invested Capital (ROIC), Return on Assets (ROA), Return on Equity (ROE), Piotroski F-Score, Altman Z-Score, Beneish M Score and Kaplan-Zingales KZ-Index.

Valuation Metrics
Price17.40
Volume158,600.00
Market Cap ($M)636.31
Enterprise Value ($M)636.31
Book Value ($M)270.99
Book Value / Share6.75
Price / Book2.35
NCAV / Sharen/a
Price / NCAVn/a
Share Statistics
Weighted Average Number Of Shares Outstanding Basic 38,095,250
Preferred Stock Shares Outstanding 0
Common Shares Outstanding 38,265,869
Weighted Average Number Of Diluted Shares Outstanding 38,610,815
Common Stock Shares Outstanding 38,200,883
Scoring Models
Piotroski F-Score2.00
Altman Z ScoreN/A
Beneish M ScoreN/A
Management Effectiveness (mra)
Return on Invested Capital (ROIC)0.09
Return on Assets (ROA)0.01
Return on Equity (ROE)0.09
Balance Sheet (mrq) ($M)
Assets2,785.55
Liabilities2,514.56
Quick Ration/a
Current Ration/a
Income Statement (mra) ($M)
Noninterest Income Out Of Scope Of Revenue From Contract With Customers0.00
Net Income23.83
Earnings Per Share Diluted0.62
Earnings Per Share Basic0.63
Cash Flow Statement (mra) ($M)
Cash From Operations41.36
Cash from Investing-237.29
Cash from Financing-237.29
Identifiers and Descriptors
CUSIP426927109
Central Index Key (CIK)1053352
Related CUSIPS
426927959

Split History

Stock splits are used by Heritage Commerce Corp. to keep share prices within reasonable numbers to encourage investment. If the share price of a security gets too high, a company can perform a stock split by issuing all shareholders an extra share, thereby halving the price of an individual share. If the share price gets too low, companies can do reverse splits. This is common when share prices drop below $1.00 and company's become in danger of being delisted. However, because of the cost, stock splits are not a normal business occurrence.

Coming soon

Related Articles

CASC: Cascadian Therapeutics Analysis and Research Report

7h - Asif

Overview Cascadian Therapeutics is a clinical-stage biopharmaceutical company focused on the development of therapeutic products for the treatment of cancer. The company's goal is to develop and commercialize novel targeted compounds that have the potential to improve the lives and outcomes of cancer patients. The company's lead clinical-stage product candidate is tucatinib, an oral, HER2-selective small molecule tyrosine kinase inhibitor. The company's pipeline also includes two preclinical-stage product candidates: CASC-578, a Chk1 kinase inhibitor, and CASC-674, an antibody program against an immuno-oncology target known as TIGIT. 2018 Merger Agreement On January 30, 2018, the company entered into an Agreement and Plan of Merger (the Merger Agreement) with Seattle Genetics, Inc., a Delaware corporation (Seattle Genetics), and Valley Acquisition Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Seattle Genetics (Merger Sub). Pursuant to the Merger ...

BAC: Bank of America Corp. Analysis and Research Report

8h - Asif

Business Overview The Corporation is a Delaware corporation, a bank holding company (BHC) and a financial holding company. When used in this report, “the Corporation” may refer to Bank of America Corporation individually, Bank of America Corporation and its subsidiaries, or certain of Bank of America Corporation’s subsidiaries or affiliates. The company's principal executive offices are located in Charlotte, North Carolina. Through its banking and various nonbank subsidiaries throughout the U.S. and in international markets, the company provide a diversified range of banking and nonbank financial services and products through four business segments: Consumer Banking, Global Wealth & Investment Management (GWIM), Global Banking and Global Markets, with the remaining operations recorded in All Other. The company operate its banking activities primarily under the Bank of America, National Association (Bank of America, N.A. or BANA) charter. At March 31, 2018, the Corporation had a...

ARWR: Arrowhead Pharmaceuticals Analysis and Research Report

2018-06-18 - Asif

Business Arrowhead develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Deemed to be one of the most important recent discoveries in life science with the potential to transform medicine, the discoverers of RNAi were awarded a Nobel Prize in 2006 for their work. Arrowhead’s RNAi-based therapeutics leverage this natural pathway of gene silencing. In fiscal 2017, Arrowhead refocused its resources on therapeutics that exclusively utilize the company’s Targeted RNAi Molecule (TRiMTM) platform technology. Therapeutics built on the TRiMTM platform have demonstrated high levels of pha...

Related News Stories

Zacks.com featured highlights include: Heritage Commerce, New Mountain, Assurant, Loews and Proteostasis

2018-03-21 zacks
Chicago, IL – March 21, 2018 - Stocks in this week’s article Heritage Commerce Corp. (HTBK - Free Report) , New Mountain Finance Corporation (NMFC - Free Report) , Assurant, Inc. (AIZ - Free Report) , Loews Corporation (L - Free Report) and Proteostasis Therapeutics, Inc. (PTI - Free Report) . (51-0)

5 Stocks in the Limelight on New Analyst Coverage

2018-03-20 zacks
New analyst coverage unearths extensive data on stocks for investors. Analysts are privy to vital information which is crucial for investment decisions. Lack of information creates chances of misinterpretation of stocks (over or undervalued). Coverage initiation on a stock by analyst(s) usually portrays higher investor inclination. Investors, on their part, often assume that there is something special in a stock to attract analysts to cover it. (40-0)

The Zacks Analyst Blog Highlights: MCBC, Bluegreen, Rocky, Tailored and Malibu

2018-03-20 zacks
Chicago, IL – March 20, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include MCBC Holdings, Inc. (MCFT - Free Report) , Bluegreen Vacations Corporation (BXG - Free Report) , Rocky Brands, Inc. (RCKY - Free Report) , Tailored Brands, Inc. (16-0)

The Zacks Analyst Blog Highlights: Apple, Adobe, Canadian National, Kellogg and Delta Air Lines

2018-03-20 zacks
Chicago, IL – March 20, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Apple (AAPL - Free Report) , Adobe (ADBE - Free Report) , Canadian National (CNI - Free Report) , Kellogg (K - Free Report) and Delta Air Lines (DAL - Free Report) . (169-0)

The Zacks Analyst Blog Highlights: Union Pacific, Kansas City, Canadian Pacific, CSX and Norfolk

2018-03-19 zacks
Chicago, IL – March 19, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Union Pacific Corp. (UNP - Free Report) , Kansas City Southern (KSU - Free Report) ,Canadian Pacific Railway Ltd. (CP - Free Report) , CSX Corp. (12-0)

CUSIP: 426927109